Generics would hit the market faster under Senate bill, saving more than $3B, says CBO

Published



Lower-price drugs would hit the market faster under a bipartisan bill awaiting a vote in the Senate, according to a score released Wednesday by the Congressional Budget Office and the Joint Committee on Taxation.

“CBO expects that the bill’s provisions would allow generic drugs … to enter the market earlier, on average, than they would under current law,” authors of the report concluded.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.